Price T Rowe Associates Inc Cerus Corp Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Cerus Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 269,165 shares of CERS stock, worth $339,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269,165

Previous 234,277 14.89%

Holding current value

$339,147

Previous $361,000 3.88%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$1.39 - $2.15 $48,494 - $75,009	34,888 Added 14.89%	269,165 $375,000
Q4 2024 Feb 14, 2025	BUY	$1.52 - $2.03 $52,734 - $70,428	34,694 Added 17.38%	234,277 $361,000
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.39 $2,159 - $3,035	1,270 Added 0.64%	199,583 $348,000
Q2 2024 Aug 14, 2024	BUY	$1.62 - $2.04 $8,812 - $11,097	5,440 Added 2.82%	198,313 $350,000
Q1 2024 May 15, 2024	BUY	$1.66 - $2.42 $14,910 - $21,736	8,982 Added 4.88%	192,873 $365,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $2.35 $68,442 - $128,671	54,754 Added 42.4%	183,891 $398,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $2,637 - $5,397	1,758 Added 1.38%	129,137 $210,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.9 $5,951 - $9,642	3,325 Added 2.68%	127,379 $314,000
Q1 2023 May 15, 2023	SELL	$2.65 - $3.81 $2,756 - $3,962	-1,040 Reduced 0.83%	124,054 $369,000
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $223,286 - $278,777	-66,061 Reduced 34.56%	125,094 $457,000
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $35,469 - $60,288	10,341 Added 5.72%	191,155 $689,000
Q2 2022 Aug 15, 2022	SELL	$4.41 - $5.69 $194 - $250	-44 Reduced 0.02%	180,814 $957,000
Q1 2022 May 16, 2022	BUY	$4.81 - $6.99 $18,263 - $26,541	3,797 Added 2.14%	180,858 $993,000
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $406,658 - $540,167	68,117 Added 62.52%	177,061 $1.21 Million
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $1,719 - $2,398	359 Added 0.33%	108,944 $663,000
Q2 2021 Aug 16, 2021	SELL	$5.35 - $6.35 $44,736 - $53,098	-8,362 Reduced 7.15%	108,585 $642,000
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $162,175 - $224,704	28,552 Added 32.3%	116,947 $703,000
Q4 2020 Feb 16, 2021	BUY	$5.25 - $8.56 $464,073 - $756,661	88,395 New	88,395 $612,000

Others Institutions Holding CERS

# of Institutions

167

Shares Held

149M

Call Options Held

24.2K

Put Options Held

44.4K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $223M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Cerus Corp Transaction History